JB has made inventions related to neural control of mechanical ventilation that are patented. The patents are assigned to the academic institution(s) where inventions were made. The license for these patents belongs to Maquet Critical Care. Future commercial uses of this technology may provide financial benefit to JB through royalties. JB owns 50% of Neurovent Research Inc (NVR). NVR is a research and development company that builds the equipment and catheters for research studies. NVR has a consulting agreement with Maquet Critical Care. The remaining authors have no conflicts to declare.

The study protocol was approved by the local research ethics board (Hamilton integrated ethics board approval number: 4671). Consent from each participating responder was inferred upon completion of the study, indicated explicitly in the cover letter of survey.